| High-Risk Insurance Divides States Temporary high-risk insurance pools, part of the national health overhaul, are exposing one of the thorniest aspects of the new law—much of its success rides on how individual states implement it. online.wsj.com |
17 High-Yielding Stocks Traded on the OTC Markets David Hunkar submits: I ran the stock screener for OTC stocks yielding more than 5% dividends and having market caps of at least $5B. The following 17 stocks met the above criteria: 1. Telstra Corporation Limited (TLSYY.PK) Current Dividend Yield: 9.40% Sector: Telecom AustraliaComplete Story » seekingalpha.com |
Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes The Burrill Report submits: GlaxoSmithKline (GSK) said that it expects to record a legal charge for the second quarter of 2010 of $2.36 billion relating to settlements of product liability litigation concerning its diabetes drug Avandia and anti-trust litigations relating to Paxil and other products, as well as the U.S. government’s investigation into its former manufacturing facility in Cidra, Puerto Rico. The company confirms it has reached an agreement in principle with the U.S. Attorney’s Office for the District of Massachusetts and the U.S. Department of Justice to pay a total of $750 million in the settlement of the Cidra investigation. The legal charge announced includes provisioning for settled cases and an estimate for those cases which GSK has received and are still outstanding. Terms of the settlements reached are confidential. The charge also includes provisioning relating to other legal matters. The U.S. subsidiary of Novartis Pharmaceuticals (NVS) said it agreed to pay $152.5 million as part of a settlement of alleged sexual discrimination. In addition, the company will fund improvements to policies and programs with approximately an additional $22.5 million. Novartis contends that the alleged behavior described during the trial in the Southern District of New York is not systemic, but acknowledged there had been problems.Complete Story » seekingalpha.com |
Ironwood Pharmaceuticals Announces Upcoming Presentation at Morgan Stanley Global Healthcare Conference [Business Wire] - CAMBRIDGE, Mass.----Ironwood Pharmaceuticals, Inc. will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 1:35 p.m. Eastern Time at the Grand Hyatt New York in New York City. us.rd.yahoo.com |
U.S. Reviews FDA Scientists' Complaints Federal inspectors have reopened a review of complaints by FDA scientists who say they were pressured by their managers to approve some high-tech medical devices, overriding their concerns about potential harm to patients. online.wsj.com |